FDA Approved: ROMIDEPSIN — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved the original ANDA for romidepsin by Fresenius Kabi USA, LLC, providing a generic version of the cancer therapy for certain T-cell lymphomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

ORIG AP for ROMIDEPSIN (ROMIDEPSIN)